Keywords: α; apha; ALT; alanine aminotransferase; ANOVA; analysis of variance; AST; aspartate transaminase; β; beta; cART; combination antiretroviral therapy; C; control; DAB; liquid 3âµ3-diaminobenzidine; DPX; distyrene/plasticizer/xylene; EFV; efavirenz; eGFR;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ATP; adenosine triphosphate; ECC2; EColiCore2; EFM; elementary flux mode; EFV; elementary flux vector; FBA; flux-balance analysis; gDW; gram dry weight; glc; glucose; GSMM; genome-scale metabolic model; LFP; linear-fractional program; LP; linear program;
Keywords: ABPAS; alcian blue periodic acid schiff; ABAF; alcian blue aldehyde fuschin; ART; antiretroviral therapy; C; control; EFV; efavirenz; FTC; emtricitabine; HCD; high calorie diet; TDF; tenofovir disoproxil fumarate; Antiretroviral treatment; Biofilm; Obesit
Keywords: 3TC; Lamivudine; ABC; Abacavir; ARV; Antiretroviral; ATV; Atazanavir; AZT; Zidovudine; d4T; Stavudine; DRV; Darunavir; EFV; Efavirenz; FTC; Emtricitabine; L&D; Labor and delivery; LOQ; Limit of quantification; LPV; Lopinavir; M8; NFV hydroxy-tert-butylami
A histomorphometric study on the effects of antiretroviral therapy (ART) combined with a high-calorie diet (HCD) on aortic perivascular adipose tissue (PVAT)
Keywords: BAT; brown adipose tissue; C; control; EFV; Efavirenz; FTC; Emtricitabine; HCD; high calorie diet; PVAT; perivascular adipose tissue; TDF; Tenofovir Disoproxil Fumarate; WAT; white adipose tissue; Aortic wall thickness; PVAT sizes; Adipocytes; Leptin inte
Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
Keywords: ART; antiretroviral therapy; TasP; Treatment-as-Prevention; NRTI; nucleoside reverse transcriptase (RT) inhibitor; NNRTI; non-nucleoside RT inhibitor; PI; protease inhibitor; INSTI; integrase strand transfer inhibitor; RAL; raltegravir; EVG; elvitegravir;
Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture
Keywords: Cytochrome P450; Allosteric effects; Cooperativity; Key determinants; Molecular modeling; 1PB; 1-pyrenebutanol; 4MP; 4-methylpyrazole; 7BQ; 7-benzyloxyquinoline; 7EC; 7-ethoxycoumarin; 7EFC; 7-ethoxy-4-trifluoromethylcoumarin; 9AP; 9-aminophenanthrene; 9E
Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation
Keywords: EFV; efavirenz; NNRTI; non-nucleoside reverse transcriptase inhibitor; HIV-1/AIDS; human immunodeficiency virus type 1 infection; SLS; sodium lauryl sulfate; HPC; hydroxypropylcellulose; HPMC; hydroxypropylmetilcellulose; NRTIs; nucleoside reverse transcr
Predicting CD4 count changes among patients on antiretroviral treatment: Application of data mining techniques
Keywords: CD4 count change; Antiretroviral treatment; Computational methods; Random Forest; Neural Network; J48, Decision tree; ABC; Abacavir; ddI; Didanosine; d4T; Stavudin; EFV; Efavirenz; FTC; Emotricitabine; LPV/r; Lopinavir/ritonavir; NFV; Nelfinavir; NNRTI; N
A study on adverse drug reactions to first-line antiretroviral therapy in HIV infected patients at a tertiary care hospital in Northeast India
Keywords: ADR; ART; HIV; WHO-UMC; EFV;
Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients
Keywords: EFV; efavirenz; cART; combined antiretroviral therapy; CNS; central nervous system; CSF; cerebrospinal fluid; CYP; cytochrome P450; UGT; UDP-glucuronosyltransferase; 8-OH-EFV; 8-hydroxy-efavirenz; 7-OH-EFV; 7-hydroxy-efavirenz; 8,14-diOH-EFV; , 8,14-dihyd
Insights into CYP2B6-mediated drug-drug interactions
Keywords: CAR; constitutive androstane receptor; C/EBP; CCAAT/enhancer-binding protein; CHOP; cyclophosphamide-doxorubicin-vincristine-prednisone; CITCO; (6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime); COUP-TF; chic
Correlation between microstructure and bioequivalence in Anti-HIV Drug Efavirenz
Keywords: EFV; Efavirenz; HAART; High Activity Antiretroviral Therapy; WPPM; Whole Powder Pattern Modelling; UNAIDS; United Nations Program on HIV/AIDS; HIV-1; human immunodeficiency virus type 1; BCS; Biopharmaceutical Classification System; API; active pharmaceut
Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs
Keywords: HIV; human immunodeficiency virus; NNRTIs; non-nucleoside reverse transcriptase inhibitors; SARs; structure and activity relationships; HAART; highly active antiretroviral therapy; RT; reverse transcriptase; NVP; nevirapine; DLV; delavirdine; EFV; efavire
The phenolic metabolites of the anti-HIV drug efavirenz: Evidence for distinct reactivities upon oxidation with Frémy's salt
Keywords: Efavirenz; Phenolic metabolites; Oxidation; Quinone-imine; Quinoline; Anti-HIV drug; CYP; cytochrome P450; EFV; efavirenz; ESI; electrospray ionization; HIV; human immunodeficiency virus type 1; HPLC-DAD; high performance liquid chromatography with diod
PedVacc 002: A phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi
Keywords: Modified vaccinia virus Ankara (MVA); Infant vaccine trial in Africa; Exposed-uninfected infants; HIV-1; Pediatric HIV-1 vaccines; KEPI vaccines; EPI vaccines; rMVA; recombinant modified vaccinia virus Ankara; HIV-1; human immunodeficiency virus type 1; H
Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa
Keywords: 3TC; Lamivudine; AOR; Adjusted Odds Ratio; ADV; adefovir; ALT; alanine transaminase; Anti-HBcAb; antibody to Hepatitis B core antigen; Anti-HBeAb; antibody to Hepatitis B e-antigen; Chronic hepatitis B; persistence of HBsAg >6months; d4T; Stavudine; ddI;
Nanomedicines in the future of pediatric therapy
Keywords: ACTs; artemisinin combined therapies; ALN; alendronate; ANMAT; Administración Nacional de Medicamentos, Alimentos y TecnologÃa Médica; ARV; antiretrovirals; AS; antisense; AUC; area-under-the-curve; BMS; burning mouth syndrome; CD; cytosine deaminase;
Research ArticleER stress in human hepatic cells treated with Efavirenz: Mitochondria again
Keywords: ER; endoplasmic reticulum; UPR; unfolded protein response; PI; protease inhibitor; HIV1; human immunodeficiency virus 1; HCV; hepatitis C virus; EFV; efavirenz; cART; combined antiretroviral therapy; ÎΨm; mitochondrial membrane potential; ROS; reactive
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba
Keywords: ART; antiretroviral therapy; CI; confidence interval; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside RTI; PI; protease inhibitor; FCR; full-class resistance; CRF; circulating recombinant form; HIV; human immunodeficiency virus; MD
Profile of stress and toxicity gene expression in human hepatic cells treated with Efavirenz
Keywords: EFV; Efavirenz; HAART; highly active antiretroviral therapy; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside reverse transcriptase inhibitor; ROS; reactive oxygen species; ÎΨm; mitochondrial transmembrane potential; DNA; polymera
Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors
Keywords: Combinatorial design; Diversity selection HIV-1; NNRTIs HEPT; Antiviral activity; RHHROCXXJZOAGP-UHFFFAOYSA-N; KMCGFILCIRJEHJ-UHFFFAOYSA-N; XXFUGXPQNOZBIR-UHFFFAOYSA-N; OFOHDLYVTOWSFB-UHFFFAOYSA-N; PWAKKEPZIWJVBA-UHFFFAOYSA-N; DTCUBSJAMNGQFU-UHFFFAOYSA-N;
Increase in epicardial fat volume is associated with greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: A serial study using non-contrast cardiac CT
Keywords: CCS; coronary calcium score; EFV; epicardial fat volume; EFVi; epicardial fat volume indexed to body surface area; NCT; non-contrast computed tomography; Epicardial fat volume; Coronary calcium score; Progression; Atherosclerosis;
Response of HIV positive patients to the long-term salvage therapy by lopinavir/ritonavir
Keywords: 3TC; lamivudin; ABC; abacavir; AZT; azidothymidin (zidovudin); d4Tstavudin; ddC; dideoxycytidin (zalcitabin); ddI; dideoxyinosin (didanosin); EFV; efavirenz; HAART; highly active antiretroviral therapy; IDV; indinavir; LPV; lopinavir; LPV/r; combination o
Effets indésirables induits par les traitements antirétroviraux
Keywords: ABC; abacavir; APV; amprénavir; ARV; antiretroviral; ASAT; aspartate aminotransférase; ATZ; atazanavir; AZT; zidovudine; ddI; didanosine; d4T; stavudine; EFV; éfavirenz; EI; effet indésirable; FTC; emtricitabine; HDL; lipoprotéine de haute densité;